Abstract

Myocardial progenitor cells represent a perspective source for cell therapy of cardiovascular disorders and are intensively studied. However, mainly the cells from adult patients are studied whereas the cells derived from children with congenital heart diseases remained poorly investigated. The aim of the present work was to obtain progenitor cells from intraoperatively obtained cardiac tissue from infants and children undergoing repair of congenital cardiac defects. Following isolation, the cells gave rise to a clonogenic, highly proliferative spindle-shaped cell population. The cells expressed markers of cardiogenic origin and were shown to differentiate towards cardiogenic lineage. This resident myocardial progenitor cells obtained from infant myocardial tissue demonstrate similar characteristics to previously described cells derived from adult myocardial tissue. This study confirms the possibility of obtaining a pool of progenitor cells from tiny tissue fragments and opens a new perspective of using these cells in regenerative medicine and further research of congenital heart disease pathogenesis.

Highlights

  • 2 Saint-Petersburg State University, 199034, Universitetskaya nab., 7-9, St. Petersburg, Russia 3 Institute of Cytology Russian Academy of Science , 194064, Tikhoretsky ave

  • Mainly the cells from adult patients are studied whereas the cells derived from children with congenital heart diseases remained poorly investigated

  • The cells expressed markers of cardiogenic origin and were shown to differentiate towards cardiogenic lineage. This resident myocardial progenitor cells obtained from infant myocardial tissue demonstrate similar characteristics to previously described cells derived from adult myocardial tissue

Read more

Summary

Introduction

2 Saint-Petersburg State University, 199034, Universitetskaya nab., 7-9, St. Petersburg, Russia 3 Institute of Cytology Russian Academy of Science , 194064, Tikhoretsky ave. Abstract Myocardial progenitor cells represent a perspective source for cell therapy of cardiovascular disorders and are intensively studied.

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.